References
- Carpenter C. C. J., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobson D. M., Katzenstein D. A., Montaner J. S. G., Richman D. D., Saag M. S., Schooley R. T., Thompson M. A., Vella S., Yeni P. G., Volberding P. A. Antiretroviral therapy for HIV infection in 1997—updated recommendations of the International AIDS Society USA panel. JAMA: Journal of the American Medical Association 1997; 277: 1962–1969
- McDougal J. S., Martin L. S., Cort S. P., Heldebrant C. M., Evatt B. L. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lym-photropic virus-III/lymphadenopathy-associated virus, with special reference to antihe-mophilic factor. Journal of Clinical Investigation 1985; 76: 875–877
- Shecterle L. M., Kelly T., Cyr J. A., St. Letter: Safe and efficient extracor-poreal method of inducing whole body hyperthermia. International Journal of Hyperthermia 1996; 12: 569–571
- Spire B., Dormont D., Barre-Sinoussi F., Montagnier J., Chermann J. C. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet 1985; 1: 188–189
- Wiedemann G. J., Katschinski D. M., Mentzel M., Mulkerin M., Robins H. I. Extracorporeal whole body hyperthermia: toxicity assessment. International Journal of Hyperthermia 1997; 13: 249–250
- Wong G. H. W., McHugh T., Weber R., Goeddel D. V. Tumor necrosis factor a selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proceedings of the National Academy of Science, USA 1991; 88: 4372–4376
- Zablow A., Shecterle L. M., Dorian R., Kelly T., Fletcher S., Foreman M., Myers R., Holton M., Sanfilippo L., Cyr J., St. Extracorporeal whole body hyperthermia treatment of HIV patients, a feasibility study. International Journal of Hyperthermia 1997; 13: 577–587